Cipla has chosen Mawdsleys as their UK distributor to hospitals.

Cipla selects Mawdsleys as their UK distributor to hospitals

Cipla selects Mawdsleys as their UK distributor to hospitals 29th May 2020

Mawdsleys is delighted to be partnering with Cipla to distribute their contract and non contract products to hospitals from 1st June 2020.

Cameron McMaster, Associate Director UK Sales at Cipla says “We have chosen Mawdsleys to take full charge of our Hospital distribution due to their experience and reputation within this sector. We look forward to a long and prosperous relationship ensuring healthcare needs are met within this arena.”

The products will be listed on Mawdsleys Online and available to order for customers from 1^st June 2020.

Other latest news

Mawdsleys and Meabco launch a Named Patient Supply program for BP-C1

Mawdsleys and Meabco A/S have launched a Named Patient Supply program to allow Oncologists within the European Union (EU) to obtain access to BP-C1 on an unlicensed basis for the treatment of metastatic breast cancer and incurable pancreatic cancer. BP-C1 is a new benzene-poly-carboxylic acids complex with cis-diammineplatinum (II)…

New CMU Contracts From Mawdsleys

November 2014 saw the start of one of the largest CMU National Contract Waves. Mawdsleys were proud to have been nominated for the biggest number of distribution agreements for this wave than any before. To ensure the new contract transition went as smoothly as possible, we provided hospitals with as…